"@"!""# @D"#. G
' "
?!
?! (*)+( 4("
$*' $*' 1 2
4("
1004. Long-T erm EPO Gene Expression in Rats Using Long-Term A Clinically Relevant Dose and Electroporation System Maida M. de las Alas,1 Drew Hannaman,1 Gerald Nakamura,1 Barry Ellefsen,1 Michael Sawdey,2 Alain Luxembourg,1 Adrian Vilalta,2 Robert M. Bernard.1 1 Ichor Medical Systems, Inc., San Diego, CA, United States; 2 Vical, Inc., San Diego, CA, United States. '
'$(
->!)/ ' >!)
$*' 3 ′
3
# " G
0 ′ >!) - >!)/ 1 E
$*'
B9" >!) E
3 >!)
>!) - >!)/ ′ 0 E
89 μ .@,589= G
>!) 89 μ ?
' >!)
-
E >!)
J / C
>!)
T:9H : @
( >!)
>D('
&9 4% ( >D(' $*'"
$*' >!)
1005. Improving Electroporation-Enhanced In Vivo Gene Delivery to Skeletal Muscle Lei Zhang,1 Georg Widera,1 Dan Holt,1 Dave Bloom,2 Fred Lindsay,2 Craig L. Cupp,2 Dietmar P. Rabussay.1 1 Dept. of Research and Development, Genetronics, Inc., San Diego, CA, United States; 2Dept. of Otolaryngology, Naval Medical Center, San Diego, CA, United States. '
( 3 3
3
' $*'
0
$*' E
Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
3
$*' E 3
" 7 -/
3 I -/
3 - / -/ 0
3 3 ! $*'
-(>'!/ E
(
$ + (1 -.%/
>
G
0
3
D
3
2
G 3
$*'
1006. Kinetics of Interleukin 10 Level in Muscle and in Blood after Electrotransfer of the Murine Interleukin 10 Encoding Plasmid in the Skeletal Muscle of the Mouse Virginie Deleuze,1 Michel Francis Bureau,1 Jean Michel Caillaud,2 Sylvie Falzon,2 Daniel Scherman.1 1 Vector Development, CNRS-Gencell, Vitry, France; 2 Biodistribution and Safety, Gencell-Aventis, Vitry, France. $
0
" (
D"89 - 7 / "
: 1 ,99 .% ,9 1 , CG-# ! *' (4('5B6,B,"6,B;8555/ D"89
>D('
D"89 1
" D"89 '
D"89
= 8& μ $*' ?
D"89
, -8& μ /
86 (
@ E D"89
D"89
D"89 > "
D"89 0 3
DJ89
1007. Improvement of Mouse Beta Thalassemia by Electrotransfer of Erythropoietin cDNA E. Payen,1 Michael Bettan,2 P. Rouyer Fessard,1 Yves Beuzard,1 Daniel Scherman.3 1 Hopital Saint Louis, Paris, France; 2CNRS ENSCP Gencell, Vitry, France; 3CNRS Gencell, Vitry, France.
-C "8/ E
S327